Table of Contents Author Guidelines Submit a Manuscript
International Journal of Cell Biology
Volume 2012, Article ID 759583, 11 pages
http://dx.doi.org/10.1155/2012/759583
Review Article

Caloric Restriction and the Nutrient-Sensing PGC-1 in Mitochondrial Homeostasis: New Perspectives in Neurodegeneration

1Department of Biology, University of Rome “Tor Vergata”, Via della Ricerca Scientifica 1, 00133 Rome, Italy
2Research Center, IRCCS San Raffaele La Pisana, Via di Val Cannuta 247, 00166 Rome, Italy

Received 7 May 2012; Accepted 8 June 2012

Academic Editor: Giuseppe Filomeni

Copyright © 2012 Daniele Lettieri Barbato et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Nunnari and A. Suomalainen, “Mitochondria: in sickness and in health,” Cell, vol. 148, no. 6, pp. 1145–1159, 2012. View at Google Scholar
  2. D. T. Johnson, R. A. Harris, S. French et al., “Tissue heterogeneity of the mammalian mitochondrial proteome,” American Journal of Physiology, vol. 292, no. 2, pp. C689–C697, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. M. B. Hock and A. Kralli, “Transcriptional control of mitochondrial biogenesis and function,” Annual Review of Physiology, vol. 71, pp. 177–203, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. D. G. Hardie, “Signal transduction: how cells sense energy,” Nature, vol. 472, no. 7342, pp. 176–177, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. M. M. Mihaylova and R. J. Shaw, “The AMPK signalling pathway coordinates cell growth, autophagy and metabolism,” Nature Cell Biology, vol. 13, no. 9, pp. 1016–1023, 2011. View at Google Scholar
  6. C. Cantó and J. Auwerx, “PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure,” Current Opinion in Lipidology, vol. 20, no. 2, pp. 98–105, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. E. H. Jeninga, K. Schoonjans, and J. Auwerx, “Reversible acetylation of PGC-1: connecting energy sensors and effectors to guarantee metabolic flexibility,” Oncogene, vol. 29, no. 33, pp. 4617–4624, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Aquilano, S. Baldelli, G. Rotilio, and M. R. Ciriolo, “trans-Resveratrol inhibits H2O2-induced adenocarcinoma gastric cells proliferation via inactivation of MEK1/2-ERK1/2-c-Jun signalling axis,” Biochemical Pharmacology, vol. 77, no. 3, pp. 337–347, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. X. Cui, “Reactive oxygen species: the achilles' heel of cancer cells?” Antioxidants & Redox Signaling, vol. 16, no. 11, pp. 1212–1214, 2012. View at Google Scholar
  10. J. Bustamante, A. Czerniczyniec, and S. Lores-Arnaiz, “Brain nitric oxide synthases and mitochondrial function,” Frontiers in Bioscience, vol. 12, no. 3, pp. 1034–1040, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Aquilano, G. Filomeni, S. Baldelli et al., “Neuronal nitric oxide synthase protects neuroblastoma cells from oxidative stress mediated by garlic derivatives,” Journal of Neurochemistry, vol. 101, no. 5, pp. 1327–1337, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Baldelli, K. Aquilano, G. Rotilio, and M. R. Ciriolo, “Glutathione and copper, zinc superoxide dismutase are modulated by overexpression of neuronal nitric oxide synthase,” International Journal of Biochemistry & Cell Biology, vol. 40, no. 11, pp. 2660–2670, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Aquilano, S. Baldelli, S. Cardaci, G. Rotilio, and M. R. Ciriolo, “Nitric oxide is the primary mediator of cytotoxicity induced by GSH depletion in neuronal cells,” Journal of Cell Science, vol. 124, part 7, pp. 1043–1054, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. G. H. Doherty, “Nitric oxide in neurodegeneration: potential benefits of non-steroidal anti-inflammatories,” Neuroscience Bulletin, vol. 27, no. 6, pp. 366–382, 2011. View at Google Scholar
  15. S. Oddi, L. Latini, M. T. Viscomi, E. Bisicchia, M. Molinari, and M. Maccarrone, “Distinct regulation of nNOS and iNOS by CB(2) receptor in remote delayed neurodegeneration,” Journal of Molecular Medicine, vol. 90, no. 4, pp. 371–387, 2012. View at Google Scholar
  16. K. Aquilano, S. Baldelli, G. Rotilio, and M. R. Ciriolo, “Role of nitric oxide synthases in Parkinson's disease: a review on the antioxidant and anti-inflammatory activity of polyphenols,” Neurochemical Research, vol. 33, no. 12, pp. 2416–2426, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Aquilano, S. Baldelli, and M. R. Ciriolo, “Glutathione is a crucial guardian of protein integrity in the brain upon nitric oxide imbalance,” Communicative & Integrative Biology, vol. 4, no. 4, pp. 477–479, 2011. View at Google Scholar
  18. K. Aquilano, P. Vigilanza, G. Rotilio, and M. R. Ciriolo, “Mitochondrial damage due to SOD1 deficiency in SH-SY5Y neuroblastoma cells: a rationale for the redundancy of SOD1,” The FASEB Journal, vol. 20, no. 10, pp. 1683–1685, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Vigilanza, K. Aquilano, G. Rotilio, and M. R. Ciriolo, “Transient cytoskeletal alterations after SOD1 depletion in neuroblastoma cells,” Cellular & Molecular Life Sciences, vol. 65, no. 6, pp. 991–1004, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. A. W. Jones, Z. Yao, J. M. Vicencio, A. Karkucinska-Wieckowska, and G. Szabadkai, “PGC-1 family coactivators and cell fate: roles in cancer, neurodegeneration, cardiovascular disease and retrograde mitochondria-nucleus signalling,” Mitochondrion, vol. 12, no. 1, pp. 86–99, 2012. View at Google Scholar
  21. N. R. Sibson, A. Dhankhar, G. F. Mason, D. L. Rothman, K. L. Behar, and R. G. Shulman, “Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 1, pp. 316–321, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. H. S. Waagepetersen, U. Sonnewald, G. Gegelashvili, O. M. Larsson, and A. Schousboe, “Metabolic distinction between vesicular and cytosolic GABA in cultured GABAergic neurons using 13C magnetic resonance spectroscopy,” Journal of Neuroscience Research, vol. 63, no. 4, pp. 347–355, 2001. View at Google Scholar
  23. T. L. Perry, J. C. Haworth, and B. H. Robinson, “Brain amino acid abnormalities in pyruvate carboxylase deficiency,” Journal of Inherited Metabolic Disease, vol. 8, no. 2, pp. 63–66, 1985. View at Google Scholar · View at Scopus
  24. J. A. Mayr, F. A. Zimmermann, C. Fauth et al., “Lipoic acid synthetase deficiency causes neonatal-onset epilepsy, defective mitochondrial energy metabolism, and glycine elevation,” American Journal of Human Genetics, vol. 89, no. 6, pp. 792–797, 2011. View at Google Scholar
  25. E. Nisoli, C. Tonello, A. Cardile et al., “Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS,” Science, vol. 310, no. 5746, pp. 314–317, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. L. W. Finley, J. Lee, A. Souza et al., “Skeletal muscle transcriptional coactivator PGC-1α mediates mitochondrial, but not metabolic, changes during calorie restriction,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 8, pp. 2931–2936, 2012. View at Google Scholar
  27. L. C. Ching, C. Y. Chen, K. H. Su et al., “Implication of AMP-activated protein kinase in transient receptor potential vanilloid type 1-mediated activation of endothelial nitric oxide synthase,” Molecular Medicine. In press.
  28. J. T. Rodgers, C. Lerin, Z. Gerhart-Hines, and P. Puigserver, “Metabolic adaptations through the PGC-1α and SIRT1 pathways,” FEBS Letters, vol. 582, no. 1, pp. 46–53, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Puigserver, Z. Wu, C. W. Park, R. Graves, M. Wright, and B. M. Spiegelman, “A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis,” Cell, vol. 92, no. 6, pp. 829–839, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Handschin and B. M. Spiegelman, “Peroxisome proliferator-activated receptor γ coactivator 1 coactivators, energy homeostasis, and metabolism,” Endocrine Reviews, vol. 27, no. 7, pp. 728–735, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. R. M. Cowell, K. R. Blake, and J. W. Russell, “Localization of the transcriptional coactivator PGC-1α to GABAergic neurons during maturation of the rat brain,” The Journal of Comparative Neurology, vol. 502, no. 1, pp. 1–18, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Puigserver and B. M. Spiegelman, “Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α): transcriptional coactivator and metabolic regulator,” Endocrine Reviews, vol. 24, no. 1, pp. 78–90, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. D. P. Kelly and R. C. Scarpulla, “Transcriptional regulatory circuits controlling mitochondrial biogenesis and function,” Genes & Development, vol. 18, no. 4, pp. 357–368, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. I. D'Errico, L. Salvatore, S. Murzilli et al., “Peroxisome proliferator-activated receptor-γ coactivator 1-α (PGC1α) is a metabolic regulator of intestinal epithelial cell fate,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 16, pp. 6603–6608, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Ciron, S. Lengacher, J. Dusonchet, P. Aebischer, and B. L. Schneider, “Sustained expression of PGC-1alpha in the rat nigrostriatal system selectively impairs dopaminergic function,” Human Molecular Genetics, vol. 21, no. 8, pp. 1861–1876, 2012. View at Google Scholar
  36. L. Cui, H. Jeong, F. Borovecki, C. N. Parkhurst, N. Tanese, and D. Krainc, “Transcriptional repression of PGC-1α by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration,” Cell, vol. 127, no. 1, pp. 59–69, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. J. St-Pierre, S. Drori, M. Uldry et al., “Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators,” Cell, vol. 127, no. 2, pp. 397–408, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. J. H. Shin, H. S. Ko, H. Kang et al., “PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease,” Cell, vol. 144, no. 5, pp. 689–702, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. W. Zhao, M. Varghese, S. Yemul et al., “Peroxisome proliferator activator receptor gamma coactivator-1alpha (PGC-1alpha) improves motor performance and survival in a mouse model of amyotrophic lateral sclerosis,” Molecular Neurodegeneration, vol. 6, no. 1, p. 51, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Martin, S. Betuing, C. Pagès et al., “Mitogen- and stress-activated protein kinase 1-induced neuroprotection in Huntington's disease: role on chromatin remodeling at the PGC-1-alpha promoter,” Human Molecular Genetics, vol. 20, no. 12, pp. 2422–2434, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Finkel, “Cell biology: a clean energy programme,” Nature, vol. 444, no. 7116, pp. 151–152, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. P. M. Barger, A. C. Browning, A. N. Garner, and D. P. Kelly, “p38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor α: a potential role in the cardiac metabolic stress response,” The Journal of Biological Chemistry, vol. 276, no. 48, pp. 44495–44501, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. P. Puigserver, G. Adelmant, Z. Wu et al., “Activation of PPARγ coactivator-1 through transcription factor docking,” Science, vol. 286, no. 5443, pp. 1368–1371, 1999. View at Publisher · View at Google Scholar · View at Scopus
  44. R. M. Anderson, J. L. Barger, M. G. Edwards et al., “Dynamic regulation of PGC-1α localization and turnover implicates mitochondrial adaptation in calorie restriction and the stress response,” Aging Cell, vol. 7, no. 1, pp. 101–111, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Cantó and J. Auwerx, “Caloric restriction, SIRT1 and longevity,” Trends in Endocrinology & Metabolism, vol. 20, no. 7, pp. 325–331, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Canto and J. Auwerx, “Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)?” Pharmacological Reviews, vol. 64, no. 1, pp. 166–187, 2012. View at Google Scholar
  47. P. Wareski, A. Vaarmann, V. Choubey et al., “PGC-1α and PGC-1β regulate mitochondrial density in neurons,” The Journal of Biological Chemistry, vol. 284, no. 32, pp. 21379–21385, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Brunet, “A CRTCal link between energy and life span,” Cell Metabolism, vol. 13, no. 4, pp. 358–360, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. C. T. Liu and G. A. Brooks, “Mild heat stress induces mitochondrial biogenesis in C2C12 myotubes,” Journal of Applied Physiology, vol. 112, no. 3, pp. 354–361, 2012. View at Google Scholar
  50. D. G. Hardie, “Energy sensing by the AMP-activated protein kinase and its effects on muscle metabolism,” Proceedings of the Nutrition Society, vol. 70, no. 1, pp. 92–99, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. W. W. Winder, E. B. Taylor, and D. M. Thomson, “Role of AMP-activated protein kinase in the molecular adaptation to endurance exercise,” Medicine and Science in Sports and Exercise, vol. 38, no. 11, pp. 1945–1949, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Crunkhorn, F. Dearie, C. Mantzoros et al., “Peroxisome proliferator activator receptor γ coactivator-1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation,” The Journal of Biological Chemistry, vol. 282, no. 21, pp. 15439–15450, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. K. E. Wellen, C. Lu, A. Mancuso et al., “The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism,” Genes & Development, vol. 24, no. 24, pp. 2784–2799, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. L. M. Sparks, H. Xie, R. A. Koza et al., “A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle,” Diabetes, vol. 54, no. 7, pp. 1926–1933, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. E. Barroso, R. Rodríguez-Calvo, L. Serrano-Marco et al., “The PPARβ/δ activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1α-lipin 1-PPARα pathway leading to increased fatty acid oxidation,” Endocrinology, vol. 152, no. 5, pp. 1848–1859, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. L. Fontana, L. Partridge, and V. D. Longo, “Extending healthy life span-from yeast to humans,” Science, vol. 328, no. 5976, pp. 321–326, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. M. A. Kiebish, D. M. Young, J. J. Lehman, and X. Han, “Chronic caloric restriction attenuates a loss of sulfatide content in PGC-1alpha-/- mouse cortex: a potential lipidomic role of PGC-1alpha in neurodegeneration,” The Journal of Lipid Research, vol. 53, no. 2, pp. 273–281, 2012. View at Google Scholar
  58. M. D. Piper and A. Bartke, “Diet and aging,” Cell Metabolism, vol. 8, no. 2, pp. 99–104, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. H. R. Park and J. Lee, “Neurogenic contributions made by dietary regulation to hippocampal neurogenesis,” Annals of the New York Academy of Sciences, vol. 1229, no. 1, pp. 23–28, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. L. W. Finley and M. C. Haigis, “The coordination of nuclear and mitochondrial communication during aging and calorie restriction,” Ageing Research Reviews, vol. 8, no. 3, pp. 173–188, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. P. H. Reddy and T. P. Reddy, “Mitochondria as a therapeutic target for aging and neurodegenerative diseases,” Current Alzheimer Research, vol. 8, no. 4, pp. 393–409, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. D. G. Hardie, “AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function,” Genes & Development, vol. 25, no. 18, pp. 1895–1908, 2011. View at Google Scholar
  63. C. Canto and J. Auwerx, “Calorie restriction: is AMPK a key sensor and effector?” Physiology, vol. 26, no. 4, pp. 214–224, 2011. View at Google Scholar
  64. L. Guarente, “Mitochondria-a nexus for aging, calorie restriction, and sirtuins?” Cell, vol. 132, no. 2, pp. 171–176, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. R. C. Scarpulla, “Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network,” Biochimica et Biophysica Acta, vol. 1813, no. 7, pp. 1269–1278, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. A. E. Civitarese, S. Carling, L. K. Heilbronn et al., “Calorie restriction increases muscle mitochondrial biogenesis in healthy humans,” PLoS Medicine, vol. 4, no. 3, p. e76, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. G. López-Lluch, N. Hunt, B. Jones et al., “Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 6, pp. 1768–1773, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. A. Chalkiadaki and L. Guarente, “Sirtuins mediate mammalian metabolic responses to nutrient availability,” Nature Review Endocrinology, vol. 8, pp. 287–296, 2012. View at Google Scholar
  69. J. Wang, H. Fivecoat, L. Ho, Y. Pan, E. Ling, and G. M. Pasinetti, “The role of Sirt1: at the crossroad between promotion of longevity and protection against Alzheimer's disease neuropathology,” Biochimica et Biophysica Acta, vol. 1804, no. 8, pp. 1690–1694, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Srivastava and M. C. Haigis, “Role of sirtuins and calorie restriction in neuroprotection: implications in Alzheimer's and Parkinson's diseases,” Current Pharmaceutical Designno, vol. 17, no. 31, pp. 3418–3433, 2011. View at Google Scholar
  71. P. Wang, T. Y. Xu, Y. F. Guan et al., “Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1-dependent adenosine monophosphate-activated kinase pathway,” Annals of Neurology, vol. 69, no. 2, pp. 360–374, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. Y. Hu, J. Liu, J. Wang, and Q. Liu, “The controversial links among calorie restriction, SIRT1, and resveratrol,” Free Radical Biology & Medicine, vol. 51, no. 2, pp. 250–256, 2011. View at Publisher · View at Google Scholar · View at Scopus
  73. L. Tan, J. T. Yu, and H. S. Guan, “Resveratrol exerts pharmacological preconditioning by activating PGC-1α,” Medical Hypotheses, vol. 71, no. 5, pp. 664–667, 2008. View at Publisher · View at Google Scholar · View at Scopus
  74. S. Cagnol and J. C. Chambard, “ERK and cell death: mechanisms of ERK-induced cell death—apoptosis, autophagy and senescence,” FEBS Journal, vol. 277, no. 1, pp. 2–21, 2010. View at Publisher · View at Google Scholar · View at Scopus
  75. Y. Liu, Y. Yang, Y. C. Ye et al., “Activation of ERK-p53 and ERK-mediated phosphorylation of Bcl-2 are involved in autophagic cell death induced by the c-met inhibitor SU11274 in human lung cancer A549 cells,” Journal of Pharmacol Sciencesno, vol. 118, no. 4, pp. 423–432, 2012. View at Google Scholar
  76. S. Fusco, C. Ripoli, M. V. Podda et al., “A role for neuronal cAMP responsive-element binding (CREB)-1 in brain responses to calorie restriction,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 2, pp. 621–626, 2012. View at Google Scholar
  77. K. Santin, R. F. da Rocha, F. Cechetti et al., “Moderate exercise training and chronic caloric restriction modulate redox status in rat hippocampus,” Brain Research, vol. 1421, pp. 1–10, 2011. View at Google Scholar
  78. C. G. Cho, H. J. Kim, S. W. Chung et al., “Modulation of glutathione and thioredoxin systems by calorie restriction during the aging process,” Experimental Gerontology, vol. 38, no. 5, pp. 539–548, 2003. View at Publisher · View at Google Scholar · View at Scopus
  79. J. S. Chang, P. Huypens, Y. Zhang, C. Black, A. Kralli, and T. W. Gettys, “Regulation of NT-PGC-1α subcellular localization and function by protein kinase A-dependent modulation of nuclear export by CRM1,” The Journal of Biological Chemistry, vol. 285, no. 23, pp. 18039–18050, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. J. S. Chang, V. Fernand, Y. Zhang et al., “NT-PGC-1alpha is sufficient to link beta3-adrenergic receptor activation to the transcriptional and physiological components of adaptive thermogenesis,” The Journal of Biological Chemistry, vol. 287, no. 12, pp. 9100–9111, 2012. View at Google Scholar
  81. K. Aquilano, P. Vigilanza, S. Baldelli, B. Pagliei, G. Rotilio, and M. R. Ciriolo, “Peroxisome proliferator-activated receptor γ co-activator 1 α (PGC-1α) and sirtuin 1 (SIRT1) reside in mitochondria: possible direct function in mitochondrial biogenesis,” The Journal of Biological Chemistry, vol. 285, no. 28, pp. 21590–21599, 2010. View at Publisher · View at Google Scholar · View at Scopus
  82. A. Safdar, J. P. Little, A. J. Stokl, B. P. Hettinga, M. Akhtar, and M. A. Tarnopolsky, “Exercise increases mitochondrial PGC-1α content and promotes nuclear-mitochondrial cross-talk to coordinate mitochondrial biogenesis,” The Journal of Biological Chemistry, vol. 286, no. 12, pp. 10605–10617, 2011. View at Publisher · View at Google Scholar · View at Scopus
  83. O. Emanuelsson, H. Nielsen, S. Brunak, and G. von Heijne, “Predicting subcellular localization of proteins based on their N-terminal amino acid sequence,” Journal of Molecular Biology, vol. 300, no. 4, pp. 1005–1016, 2000. View at Publisher · View at Google Scholar · View at Scopus
  84. V. K. Mootha, J. Bunkenborg, J. V. Olsen et al., “Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria,” Cell, vol. 115, no. 5, pp. 629–640, 2003. View at Publisher · View at Google Scholar · View at Scopus
  85. C. K. Sen, “Glutathione homeostasis in response to exercise training and nutritional supplements,” Molecular and Cellular Biochemistry, vol. 196, no. 1-2, pp. 31–42, 1999. View at Publisher · View at Google Scholar · View at Scopus
  86. T. L. Merry and G. K. McConell, “Skeletal muscle glucose uptake during exercise: a focus on reactive oxygen species and nitric oxide signaling,” IUBMB Life, vol. 61, no. 5, pp. 479–484, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. I. K. Sundar, S. Caito, H. Yao, and I. Rahman, “Oxidative stress, thiol redox signaling methods in epigenetics,” Methods in Enzymology, vol. 474, pp. 213–244, 2010. View at Google Scholar · View at Scopus
  88. S. Cardaci, G. Filomeni, G. Rotilio, and M. R. Ciriolo, “P38MAPK/p53 signalling axis mediates neuronal apoptosis in response to tetrahydrobiopterin-induced oxidative stress and glucose uptake inhibition: implication for neurodegeneration,” Biochemical Journal, vol. 430, no. 3, pp. 439–451, 2010. View at Publisher · View at Google Scholar · View at Scopus
  89. G. Filomeni, S. Cardaci, A. M. Da Costa Ferreira, G. Rotilio, and M. R. Ciriolo, “Metabolic oxidative stress elicited by the copper(II) complex [Cu(isaepy)2] triggers apoptosis in SH-SY5Y cells through the induction of the AMP-activated protein kinase/p38MAPK/p53 signalling axis: evidence for a combined use with 3-bromopyruvate in neuroblastoma treatment,” Biochemical Journal, vol. 437, no. 3, pp. 443–453, 2011. View at Publisher · View at Google Scholar · View at Scopus
  90. J. Chao, M. S. Yu, Y. S. Ho, M. Wang, and R. C. Chang, “Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity,” Free Radical Biology & Medicine, vol. 45, no. 7, pp. 1019–1026, 2008. View at Publisher · View at Google Scholar · View at Scopus
  91. D. Albani, L. Polito, S. Batelli et al., “The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by α-synuclein or amyloid-β (1-42) peptide,” Journal of Neurochemistry, vol. 110, no. 5, pp. 1445–1456, 2009. View at Publisher · View at Google Scholar · View at Scopus
  92. P. H. Reddy, P. Mao, and M. Manczak, “Mitochondrial structural and functional dynamics in Huntington's disease,” Brain Research Reviews, vol. 61, no. 1, pp. 33–48, 2009. View at Publisher · View at Google Scholar · View at Scopus